Immediate Impact

2 from Science/Nature 53 standout
Sub-graph 1 of 18

Citing Papers

Dual-Locked Fluorescence Probe for Monitoring the Dynamic Transition of Pulmonary Macrophages
2025 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
22 intermediate papers

Works of Thaddeus Beck being referenced

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
2013
Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer
2006

Author Peers

Author Last Decade Papers Cites
Thaddeus Beck 869 447 378 426 21 1.1k
Nina Karaseva 924 738 334 206 20 1.3k
P Libert 998 827 314 268 27 1.3k
Joseph Montecalvo 657 732 308 314 27 1.1k
Jung Wook Park 638 710 653 229 27 1.4k
Justin Fairchild 962 291 299 516 18 1.1k
Richard Létourneau 749 274 209 231 26 981
V. Georgoulias 826 259 269 174 38 1000
Henry Xiong 758 297 341 224 20 1.1k
Christopher W. Lee 511 428 320 125 23 952
Alfredo Romano 831 277 142 213 19 989

All Works

Loading papers...

Rankless by CCL
2026